ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04668	TNF signaling pathway	16/119	120/7206	8.14434393567e-11
ko04060	Cytokine-cytokine receptor interaction	15/119	191/7206	4.76754038655e-07
ko04621	NOD-like receptor signaling pathway	12/119	157/7206	9.5397729132e-06
ko05323	Rheumatoid arthritis	9/119	89/7206	1.41465469607e-05
ko05161	Hepatitis B	12/119	173/7206	2.54969809775e-05
ko04064	NF-kappa B signaling pathway	9/119	96/7206	2.6195972667e-05
ko04380	Osteoclast differentiation	10/119	134/7206	6.72471558797e-05
ko04217	Necroptosis	11/119	178/7206	0.000159600505666
ko01522	Endocrine resistance	9/119	124/7206	0.000194790174111
ko04620	Toll-like receptor signaling pathway	8/119	100/7206	0.000229070863355
ko05164	Influenza A	10/119	167/7206	0.000412569117141
ko04658	Th1 and Th2 cell differentiation	7/119	96/7206	0.000993872389754
ko05167	Kaposi's sarcoma-associated herpesvirus infection	10/119	191/7206	0.00117435524439
ko05134	Legionellosis	6/119	74/7206	0.00132638562882
ko04931	Insulin resistance	8/119	137/7206	0.00185438154248
ko05321	Inflammatory bowel disease (IBD)	5/119	56/7206	0.00220241400546
ko05131	Shigellosis	6/119	82/7206	0.00225312949614
ko04657	IL-17 signaling pathway	6/119	87/7206	0.00303978368848
ko04932	Non-alcoholic fatty liver disease (NAFLD)	9/119	182/7206	0.00305193673891
ko05120	Epithelial cell signaling in Helicobacter pylori infection	6/119	92/7206	0.00401591157664
ko04623	Cytosolic DNA-sensing pathway	4/119	41/7206	0.00446903270602
ko04722	Neurotrophin signaling pathway	8/119	160/7206	0.00483532217071
ko05205	Proteoglycans in cancer	11/119	271/7206	0.0049994121652
ko05142	Chagas disease (American trypanosomiasis)	7/119	130/7206	0.00556382946887
ko05100	Bacterial invasion of epithelial cells	6/119	99/7206	0.00574986520546
ko05146	Amoebiasis	6/119	99/7206	0.00574986520546
ko04915	Estrogen signaling pathway	7/119	131/7206	0.00579927568198
ko04062	Chemokine signaling pathway	9/119	201/7206	0.00586010227273
ko04933	AGE-RAGE signaling pathway in diabetic complications	7/119	135/7206	0.00681642129746
ko05219	Bladder cancer	4/119	48/7206	0.00786084959835
ko04210	Apoptosis	8/119	180/7206	0.00964477927367
ko05168	Herpes simplex infection	8/119	182/7206	0.0102721471527
ko05160	Hepatitis C	7/119	153/7206	0.0130993280979
ko05162	Measles	6/119	120/7206	0.0141922384022
ko05133	Pertussis	5/119	87/7206	0.0142335796421
ko04662	B cell receptor signaling pathway	5/119	88/7206	0.0148971064052
ko04630	Jak-STAT signaling pathway	6/119	132/7206	0.0217161916328
ko04672	Intestinal immune network for IgA production	3/119	37/7206	0.0226924772173
ko05132	Salmonella infection	5/119	98/7206	0.022697458921
ko05410	Hypertrophic cardiomyopathy (HCM)	5/119	100/7206	0.0245232821022
ko04144	Endocytosis	11/119	342/7206	0.0282577871145
ko05166	HTLV-I infection	10/119	292/7206	0.0291566510349
ko05014	Amyotrophic lateral sclerosis (ALS)	4/119	74/7206	0.033578780383
ko04115	p53 signaling pathway	4/119	74/7206	0.033578780383
ko05152	Tuberculosis	7/119	187/7206	0.0347714217189
ko05140	Leishmaniasis	4/119	75/7206	0.0350329229202
ko05144	Malaria	3/119	45/7206	0.0377070701469
ko04670	Leukocyte transendothelial migration	6/119	151/7206	0.038486486503
ko04215	Apoptosis - multiple species	3/119	47/7206	0.0420867241175
ko04080	Neuroactive ligand-receptor interaction	2/119	423/7206	0.047653151974